Telitacicept for inflammatory muscle disease (myositis) trial
Treatments studied
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This trial tests an investigational drug called Telitacicept for people with inflammatory myopathies (muscle inflammation). It aims to see if the drug can help when standard treatments haven't worked well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with an inflammatory muscle disease (like myositis).
- Your symptoms have not improved enough after trying steroids or other immune medicines.
- You are not pregnant, breastfeeding, or planning a pregnancy.
- You do not have an active infection (like tuberculosis, hepatitis, or HIV) or a history of cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called Telitacicept for people with generalized myasthenia gravis (gMG). The goal is to see if it can reduce muscle weakness and improve daily function. You may be able to join if you have moderate to severe symptoms and have not had recent thymoma or other serious health issues.
This trial is testing a new drug called telitacicept for children with ocular myasthenia gravis (eye muscle weakness). It aims to see if the drug is safe and effective when added to standard treatments.
This trial tests a new medicine called telitacicept combined with low-dose steroids for people with hard-to-treat myasthenia gravis. The goal is to see if this combination can better control symptoms that haven't improved with standard treatments.
This trial tests a new drug, telitacicept, for people with myasthenia gravis that only affects the eyes (ocular myasthenia gravis). The goal is to see if it can improve symptoms like droopy eyelids or double vision.
This trial tests a new drug called telitacicept for people with rheumatoid arthritis (RA) that hasn't been controlled by multiple standard treatments. It aims to see if telitacicept can help reduce inflammation and improve symptoms.
This trial tests telitacicept to improve lupus nephritis (inflammation of the kidneys caused by lupus). It targets people with active kidney disease confirmed by biopsy and compares outcomes while you receive standard steroid plus mycophenolate treatment.
Hear when a new Inflammatory Myopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.